Search Results - "Journal of opioid management"

Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey by Bell, Timothy, Annunziata, Kathy, Leslie, John B

“…To characterize the impact of opioid-induced constipation (OIC) on healthcare resource use, work productivity, and health-related quality of life (HRQOL) in…”
Get more information

Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management by Holzer, Peter, Ahmedzai, Sam H, Niederle, Norbert, Leyendecker, Petra, Hopp, Michael, Bosse, Björn, Spohr, Ingrid, Reimer, Karen

“…Opioids are the mainstay of management for patients with cancer-related pain. Although the analgesic efficacy of opioid therapy is well documented, the recent…”
Get more information

Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain by Vorsanger, Gary J, Xiang, Jim, Gana, Theophilus J, Pascual, Maria Luz G, Fleming, R Rosanna B

“…This study evaluated the safety and efficacy of tramadol ER 300 mg and 200 mg versus placebo once daily in the treatment of chronic low back pain, using an…”
Get more information

Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers by Jamison, Robert N, Sheehan, Kerry Anne, Scanlan, Elizabeth, Matthews, Michele, Ross, Edgar L

“…There is growing concern of medication misuse and noncompliance among patients with chronic pain prescribed opioids for pain. The aim of this survey was to…”
Get more information

Partial Agonist, Full Barrier: A Case-Based Discussion on Challenges with Buprenorphine in Chronic Pain Management by Hershman, Tonya S, Park, Michelle

“…More patients are on chronic opioids, as patients who were initially started on full agonist opioids for cancer-related pain are living longer. Despite doing…”
Get more information

Buprenorphine: The Opioid that Cried 'Partial Agonist' by Bettinger, Jeffrey J, Cleary, Jacqueline

“…Although buprenorphine use has increased dramatically over the past decade, its unique pharmacologic and pharmacokinetic profile often leads to misconceptions…”
Get more information

Buprenorphine Use in the Military Health System (MHS) by Cornish, Nicole

“…The CPG's updated recommendation is supported by buprenorphine's lower risk of overdose and misuse.(1) In comparison to full mu-opioid agonists, buprenorphine…”
Get more information

Prescription opioids following herpes zoster: An observational study among insured adults, United States, 2007-2021 by Dooling, Kathleen, Leung, Jessica, Bohm, Michele K

“…The opioid overdose epidemic has resulted in hundreds of thousands of overdose deaths in the United States (US). One indication for opioids is herpes zoster…”
Get more information

Association between buprenorphine capacity rates and percentages of ethnic/racial minorities at the county level in the United States by Nedjat, Saharnaz, Fleming, Marc

“…This study investigated the association between patient treatment capacity rates and the percentage of racial/ethnic minorities at the county level. Ecological…”
Get more information

Buprenorphine: Opioid Agonist-Antagonist for Refractory Pain of Sickle Cell Disease Patients During Hematopoietic Stem Cell Transplant, Uncontrolled By Full-Agonist Opioids by Sakae, Mayuko

“…Bone marrow transplant (BMT) offers potential cure for cancer and a spectrum of otherwise incur- able diseases. The BMT process can cause multi-systemic pain…”
Get more information

The influence of guidelines on opioid prescribing practices after pe-diatric anterior cruciate ligament reconstruction by Hudson, Tanner, Berkay, Fehmi, Minhas, Arjun, Huff, Scott, Henningsen, Joseph, Erb, Eric, Froehle, Andrew W, Albert, Michael C

“…To report opioid prescription patterns after pediatric anterior cruciate ligament reconstruction (ACLR) and identify if the implementation of the opioid…”
Get more information

Why pharmacogenetic testing should be reimbursed by Medicare and commercial health insurance by Pesce, Amadeo

Get more information

Effectiveness of a discharge analgesia guideline on discharge opioid prescribing after a surgical procedure from a tertiary metropolitan hospital by Jauregui, Katelyn, Liu, Shania, Patanwala, Asad, Begley, David, Khor, Kok Eng, Bugeja, Bernadette, Fong, Ian, Rimington, Joanne, Penm, Jonathan

“…The primary objective of this study was to evaluate the effectiveness of a discharge analgesia guideline on the number of days' supply of opioid analgesics…”
Get more information

Opioid-related clinical outcomes and associated healthcare costs following abuse/misuse of oxycodone formulations: A HEOR analysis from real-world data by Green, Jody L, Dailey-Govoni, Taryn, Vosburg, Suzanne K

“…The United States (US) opioid epidemic is a continued burden on the healthcare system and on the lives of individuals affected by the consequences of opioid…”
Get more information

Emerging Trends in Perioperative Buprenorphine Management by Engle, Amanda, Cleary, Jacqueline, Winans, Amanda

“…Historically, there has been limited evidence and no clear consensus suggesting best practices for perioperative buprenorphine management (PBM). Previously…”
Get more information

Conversion of CII Opioid Medications to Buprenorphine in the Chronic Pain Population - Insights and Clinical Pearls by Zimmerman, Amanda

“…There is a great deal of confusion associated with conversion from CII opioid to buprenorphine products. The data presented supports that patients can be…”
Get more information

Overcoming challenges of prescribing long-term opioid therapy in residency clinics by Brown, Kathryn, Farley, Joel, Golberstein, Ezra, Satin, David, Harper, Peter, Pereira, Chrystian, Slattengren, Andrew H, Riper, Kristi Van, Schafer, Katherine Montag

“…To describe the impact of a standardized opioid prescribing intervention when implemented in three family medicine (FM) residency training -…”
Get more information

The "Micro"cosm: Magnifying the Nuance of Low Dose Buprenorphine Inductions by Uritsky, Tanya, Casey, Emily

“…Now that the X-wavier is a thing of the past, patients with Opioid Use Disorder (OUD) who previously lacked access to buprenorphine may have access to lower…”
Get more information

Buprenorphine for the Treatment of Pain in Cancer Patients by Chwistek, Marcin, Sherry, Dylan, Kinczewski, Leigh

“…Opioids remain the cornerstone for the treatment of moderate to severe cancer pain. Due to benefits over full agonist opioids (FAO), buprenorphine has emerged…”
Get more information

Fentanyl dose-sparing in polyarthritic rats requires full agonism at 5-HT 1A receptors: Comparison between NLX-112, (±)8-OH-DPAT, and buspirone by Depoortere, Ronan, Bardin, Laurent, Newman-Tancredi, Adrian

“…NLX-112 (a.k.a. F13640, befiradol) is a highly selective and fully efficacious agonist at 5-hydroxytryptamine (5-HT ) receptors. It has been shown to be…”
Get more information